Skip to content

BRDS — Bridgebio Pharma Inc Institutional Holders · Q1 2026

Who owns Bridgebio Pharma Inc (BRDS)? 1 institutions reported holding $12,996 in SEC 13F filings for Q1 2026 (period ended 2026-03-31). Largest holders: Accent Capital Management, LLC ($12,996).

RankInstitutionValueSharesChange
1Accent Capital Management, LLC$12,996175Trimmed

Source: SEC Form 13F filings · as of 2026-03-31